Optical Biometry Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The optical biometry devices market was valued at USD 369.35 million in 2025 and estimated to grow from USD 389.61 million in 2026 to reach USD 537.16 million by 2031, at a CAGR of 6.63% during the forecast period (2026-2031). This report is segmented by Technology (Swept-Source Optical Coherence Tomography (SS-OCT) Biometers, and More), Device Type (Non-Contact Optical Biometry Devices, Contact Optical Biometry Devices), Application (Cataract Surgery Planning, and More), End-User (Hospitals, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Optical Biometry Devices Market Trends and Insights

Rising Cataract Surgery Volumes in Aging Populations

Cataract prevalence rises with age and continues to shape the long-term need for preoperative eye measurements. Cataract surgical coverage reached 48.2% globally in 2025 and is projected to reach 52.3% by 2030. The expected improvement remains below the stated decade target, which leaves a large backlog of patients needing treatment. The WHO African region recorded effective cataract surgical coverage of 23.6% in 2025, showing the scale of the access gap. The optical biometry devices market benefits when cataract programs expand because each surgery requires dependable measurements before lens selection. Suppliers with durable and portable products are better positioned where first-time equipment placement matters more than replacement demand.

Shift to Swept-Source OCT for Dense Cataracts and Complex Eyes

Swept-Source Optical Coherence Tomography uses a 1,050 nm wavelength that can obtain measurements through denser cataracts than some earlier optical methods. A 2026 prospective study reported that ARGOS with the Barrett Universal II formula placed 98% of eyes within ±0.50 D of refractive prediction error across normal and long axial lengths. This performance matters for patients with high myopia and for premium toric or multifocal lens procedures. The optical biometry devices market is gaining from this clinical use because complex cases are often treated in high-volume surgical centers. When a biometer obtains dependable readings in difficult eyes, clinics have less reason to retain immersion A-scan ultrasound as a routine fallback. That pattern can support replacement purchases where clinical teams seek one device for both standard and challenging cases.

High Capital Cost and Budget Constraints in Emerging Markets

Capital budgets limit the adoption of advanced optical instruments in district hospitals and smaller outpatient centers. Many facilities in South Asia, Southeast Asia, and sub-Saharan Africa continue to rely on ultrasound because funding and reimbursement are limited. Without payment mechanisms for optical biometry, providers may struggle to recover the cost through procedure revenue. This can keep facilities on lower-accuracy equipment even when clinicians prefer optical measurements. Guidance for low-resource eye care settings identifies maintenance, calibration, and fallback measurement practices as important quality issues. The optical biometry devices market therefore faces a slower adoption path where equipment finance, service capacity, and reimbursement remain weak.

Other drivers and restraints analyzed in the detailed report include:

• Premium IOL Adoption Increasing Measurement Requirements
• Integration of Biometry with Digital Cataract Planning Workflows
• Shortage of Trained Ophthalmic Technicians and Biometry Operators

Segment Analysis

Swept-source optical coherence tomography biometers held 48.23% revenue share in 2025. They are widely used in tertiary surgical centers that need readings through dense cataracts and posterior corneal data for toric lens planning. A 2026 comparison of CASIA2 and IOLMaster 700 examined the agreement of ocular biometry and lens calculation performance in cataract patients.

Optical low-coherence reflectometry is the fastest-growing technology category, with a projected 7.28% CAGR through 2031. Its price position and validated performance in routine cataract cases support demand among mid-volume providers, while the Topcon Aladdin platform combines OLCR biometry, corneal topography, calculation tools, and DICOM or HL7 connectivity. Within the optical biometry devices industry, the technology choice increasingly reflects patient mix, workflow needs, and capital limits rather than a single performance standard.

Non-contact optical biometry devices captured 53.27% revenue share in 2025. They reduce corneal compression concerns associated with contact ultrasound and support patient-friendly testing. Automated alignment can help clinics manage high patient throughput during cataract surgery sessions. Their use in routine preoperative care supports a large installed base across the optical biometry devices market, hospitals, and ophthalmology clinics.

Contact optical biometry devices are the fastest-growing device type, with a projected 8.34% CAGR through 2031. Their demand reflects clinical conditions in which severe media opacity can limit non-contact optical readings. Hybrid systems that provide contact and non-contact options can address varied patient severity within one facility. The optical biometry devices market retains a role for contact modalities even as non-contact testing remains the preferred approach for standard cases.

Complete Report Scope:

• By Technology
  • Swept-Source Optical Coherence Tomography (SS-OCT) Biometers
  • Optical Low-Coherence Reflectometry (OLCR) Biometers
  • Partial Coherence Interferometry (PCI) Biometers
• By Device Type
  • Non-Contact Optical Biometry Devices
  • Contact Optical Biometry Devices
• By Application
  • Cataract Surgery Planning
  • Intraocular Lens (IOL) Power Calculation
  • Refractive Lens Exchange Planning
  • Other Applications
• By End-User
  • Hospitals
  • Ophthalmology Clinics and Specialized Eye Care Centers
  • Ambulatory Surgical Centers
  • Diagnostic and Vision-Care Centers
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 48.36% of the optical biometry devices market share in 2025. The region benefits from high cataract surgery volumes, dense ophthalmology networks, premium lens use, and reimbursement support. The United States remains an important launch setting for integrated pretesting and workflow products, and Topcon Healthcare received FDA 510(k) clearance for its OMNIA 4-in-1 automated pretesting solution in November 2025. Academic medical centers and specialist practices also provide clinical evidence that supports wider adoption of high-end biometry platforms.

Europe is a significant contributor to revenue, with Germany, the United Kingdom, and France among its larger national markets. Universal health systems fund cataract procedures and commonly treat biometry as a standard preoperative step. Established reimbursement can slow upgrades when existing devices meet approved clinical protocols and reduce replacement urgency even where newer SS-OCT systems offer additional features. The optical biometry devices market faces a higher compliance burden in Europe, while established suppliers can use certified portfolios to protect access.

Asia-Pacific is projected to be the fastest-growing region, with a projected 8.4% CAGR through 2031. The optical biometry devices market in China, India, South Korea, and Japan gains support from private ophthalmology expansion, premium lens adoption, and local manufacturing. The Middle East and Africa show a sharp divide between premium demand in Gulf Cooperation Council markets and limited access in sub-Saharan Africa. South America remains a smaller growth area where import tariffs and restricted reimbursement constrain adoption, although private clinics in major cities continue to create demand.

List of Companies Covered in this Report:

• Alcon
• AMETEK, Inc.
• Bausch + Lomb Corporation
• Canon
• Carl Zeiss
• Haag-Streit AG
• Heidelberg Engineering
• HEINE Optotechnik
• HOYA
• Danaher
• Medmont International
• Nidek
• OCULUS Optikgerate GmbH
• Optovue, Inc.
• Revenio Group Oyj
• SANTEC CORPORATION
• Tomey
• Topcon
• Visionix Ltd.
• Ziemer Group

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support